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1. Introduction 
Phosphorylase kinase (ATP:phosphorylase phos- 
photransferase, EC 2.7.1.38) is a regulatory enzyme 
in the cascade of reactions associated with glycogenol- 
ysis. The enzyme from white skeletal muscle of the 
rabbit is a hexadecamer of 4 dissimilar subunits, 
o&y48 4 [ 11, whose activity is markedly stimulated 
by PM levels of Ca2+ [2-4]. Although the 7 subunit 
has catalytic activity [5,6] and the 6 subunit is iden- 
tical to cahnodulin [7], the roles of the two largest 
subunits, (Y and 0, have not been clearly defined. Modi- 
fication of both the /.I and 7 subunits was observed [8] 
employing aseries of alkylating ATP affinity labels, 
but inactivation was found to be correlatedwith modifi- 
cation of the /.I subunit. We have also sought o exploit 
affinity labeling by ATP analogs as a method for iden- 
tification of possible catalytic and regulatory sites on 
individual subunits as they occur in the native enzyme. 
We have found that MM levels of the photolabel 8-azido 
ATP cause preferential labeling of the /I subunit of 
phosphorylase kinase [9]. The 2’,3’-dialdehyde riv- 
ative of ATP was also found to be an effective affinity 
label at very low concentrations, but it did not form 
an isolatable derivative which would have allowed 
identification of modified subunits [lo]. Here, we 
extend these studies on the interaction of phosphoryl- 
ase kinase with ATP affinity labels by reporting on its 
interaction with 5’-(p-fluorosulfonylbenzoyl)adenosine 
(5’.FSBA). Its use revealed the existence of a binding 
site on phosphorylase kinase with a high affinity for 
free ADP. In the absence of Mg2+ this nucleotide 
exclusively protected the /3 subunit against modiiica- 
tion by 5’-FSBA. 
2. Materials and methods 
Purification of phosphorylase kinase and phos- 
phorylase b, the assay for phosphorylase kinase activ- 
ity, and the procedure for gel electrophoresis were 
done as in [lo]. An Mr of 335 000 for each tetramer 
(@yS) of phosphorylase kinase was utilized for cal- 
culating the stoichiometry of labeling [111. For fig.2 
and table 1 phosphorylase kinase concentrations were 
determined following [ 121. 
5’-FSBA was synthesized as in [ 131 and was 
recrystallized from dimethylformamide. For the syn- 
thesis of 5’-[2-3H]FSBA the reaction utilized 5 mC!i 
[ 2-3H] adenosine and was scaled down to 1/2Oth. 
5’- [2-3H] FSBA was purified over Silica gel-60 [ 141 
and was used at spec. act. 2.4 X 1013 dpm/mol. 
[Y-~~P]ATP was prepared as in [ 151. 
3. Results and discussion 
Incubation of phosphorylase kinase at pH 8.2 and 
30°C with mM levels of 5’-FSBA resulted in the rapid 
loss of enzymatic activity (fig.1); incubation of the 
kinase in the absence of the analog, but under other- 
wise identical conditions, had very little effect. When 
inactivation of phosphorylase kinase was carried out 
with increasing [5’-FSBA], saturation kinetics were 
observed. This data is plotted in the inset of fig.1 as 
E,/(E,-E) vs the reciprocal of [5’-FSBA], where E, 
is the activity of enzyme Incubated in the absence of 
inhibitor, and E is the activity of enzyme incubated 
with 5’-FSBA. From the intercept on the axis of the 
abscissa anapp. Ki of 0.8 mM was obtained for 5’-FSBA. 
A 2.5-fold Increase in the rate of inactivation was 
caused by the synergistic action of Mg2+ and Ca2+ at 
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10 mM and -0.1 mM, respectively. Separately, a <50% 
increase in the rate of inactivation was observed when 
Mg’+ alone were added to the modification reaction, 
whereas no change in the inactivation rate was caused 
by Ca2+ in the absence of Mg2+. In [lo] we observed 
a synergistic effect’of Ca2+ on the inactivation of phos- 
phorylase kinase by an affinity label of ATP with the 
2’,3’dialdehyde derivative of ATP. This suggests hat 
the 2 ATP-analogs may inactivate phosphorylase 
kinase at a common site. 
Modification of phosphorylase kinase by 5’-[‘HI- 
FSBA resulted in the incorporation of radioactive 
Fig.1. Inactivation by 5’-FSBA. Non-activated phosphorylase 
kinase (0.2 mgjml) was inactivated at 30°C by 5’-FSBA 
(1.0 mM) in the presence of Hepes buffer (30 mM, pH 8.2), 
dimethylformamide (4%, v/v) and EDTA (0.2 mM). At the 
indicated times aliquots were initially diluted 60-fold with 
cold buffer (40 mM Hepes, 30 mM mercaptoethanol, pH 6.8) 
and then diluted 6-fold into an assay mixture containing in 
final cont.: kinase (0.55 Mg/ml); phosphorylase (7.8 mg/ml); 
MgATP (10 mM Mg(CH,CO,),, 1.5 mM [3aP]ATP at 15.5 Ci! 
mol); CaCl, (0.2 mM); EDTA (0.1 mM); mercaptoethanol 
(12 mM); and buffer (92 mM Hepes, pH 8.0). After 3 mm at 
30°C aliquots were removed for the determination of “P 
incorporation into protein: (0) incubation without 5’-FSBA; 
(0) incubation with 5’-FSBA. Inset: Determination of an app. 
Ki for 5’-FSBA. Inactivation of phosphorylase kinase was carried 
out with increasing [ 5’-FSBA] (up to 1.6 mM). Incubation 
and assay conditions were as above except that dimethylfor- 
mamide was 5% in the inactivation mixture and [ “P]ATP 
was 2.0 mM at 6.8 Ci/mol in the assay mixture. 
analog into the cw,fl and 7 subunits; however, labeling 
of the /3 subunit was 2-3-times greater. Incorporation 
of 3H into the 6 subunit was not determined because 
the protein band corresponding to this subunit was 
too diffuse under our electrophoresis conditions to 
ensure a quantitative r covery of protein. In order to 
determine which of the 3 subunit-modifications was 
responsible for the loss of enzymatic activity, inacti- 
vation by 5’.FSBA and incorporation of the analog 
into the individual subunits were determined simul- 
taneously (table 1). The results howed, however, that 
inactivation of phosphorylase kinase by 5’-FSBA can- 
Table 1 
Inactivation and subunit labeling by 5’-FSBA 
Inactivation Inactivation Subunit-labeling 
time (min) (%) (mol5’-FSBA/mol subunit) 
(Y P r 
5 33.6 i 3.5 0.25 * 0.09 0.54 f 0.04 0.26 f 0.05 
10 56.1 f 2.1 0.45 * 0.08 1.00 * 0.24 0.41 f 0.07 
15 66.3 f 0.8 0.76 + 0.13 1.66 f 0.20 0.68 f 0.09 
Non-activated phosphorylase kinase (0.44 mg/ml) was inactivated by 5’-[ 2-‘H] FSBA 
(0.8 mM) at 30°C in the presence of EDTA (0.2 mM), dimethylformamide (4%, 
v/v), and buffer (50 mM Hepes, pH 8.2). At the indicated times aliquots of the 
reaction were stopped by addition of a smaB aliquot of dithiothreitol (final cont. 
100 mM). Residual activity was determined as in 0.1. In addition, aliquots of 
each sample were faltered over Sephadex G-50 [ 161 followed by SDS gel electro- 
phoresis to determine the incorporation of 3H into the individual subunits. The 
values shown are averages with standard deviations of results obtained in triplicate 
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Fig.2. Effect of ADP on subunit-labeling by 5’-FSBA. Non- 
activated phosphorylase kinase (0.8 mglml) was inactivated 
by 5’-[ 2-JH]FSBA (0.5 mM) in the presence of EGTA 
(0.2 mM), dimethylformamide (4%, v/v), Hepes buffer 
(50 mM, pH 8.2), and the indicated [ADP]. After 15 min at 
30°C the reactions were terminated by addition of a small 
aliquot of dithiothreitol (final cont. 100 mM). The modified 
enzyme was separated from excess reagent by filtration over 
Sephadex G-50 [ 161 and then SDS gel electrophoresed for 
determination of 3H incorporation into the individual sub- 
units: (A) minus Mga+; (B) plus 10 mM Mg(CH,CO,), in the 
modification; (4,~) a; (o,e) p; (o,e) 7. 
not be directly correlated with labeling of any partic- 
ular subunit, because incorporation of the analog into 
each of the 3 subunits was sufficient o account for 
the loss of enzymatic activity. 
To determine the specificity of modification, we 
tested the ability of AMP, ADP and ATP to protect 
individual subunits from being modified. The extent 
to which a nucleotide blocks labeling in a given time, 
along with the concentration ofnucleotide necessary 
to achieve the protection, can indicate the specificity 
of the protected site for the affinity label. The most 
dramatic results were obtained with ADP. In the 
absence of Mg*+, this nucleotide was found to exclu- 
sively protect he 0 subunit from labeling by 5’-FSBA, 
and the concentration of ADP necessary for this pro- 
tection was surprisingly low (fig.2A). A decrease of 
X0% in labeling of the 0 subunit by 0.5 mM 5’-FSBA 
was obtained in the presence of 50 MM ADP, at which 
point the effect of ADP reached aplateau. Under the 
conditions in tigdA, 8.8 PM ADP was sufficient o 
obtain the half-maximal effect, which indicates that 
free ADP binds rather tightly to the enzyme. 
Fig.2B shows the effect of ADP on subunit-labeling 
in the presence of 10 mM Mg2+, which was consider- 
ably different than that observed in the absence of 
this ion. Under these conditions labeling of the 7 sub- 
unit, as well as labeling of the /3 subunit, was signifi- 
cantly reduced in the presence of ADP. For the 7 sub- 
unit this effect of ADP in the presence of Mg” reached 
a plateau at -50 PM ADP. The protective ffect on 
the 0 subunit did not reach a plateau even at 200 /.LM 
ADP. 
In separate xperiments he effects of 0.2 mM 
AMPand 0.2 mM ATP on subunit labeling by 5’-FSBA 
were determined. When tested under the conditions 
in fig.2, this concentration of AMP had no effect on 
labeling of any of the subunits. The same concentra- 
tion of ATP was found to protect all 3 subunits to 
approximately the same extent; however, the protec- 
tion by ATP was significant only in the presence of 
Mg’+. 
Because ADP was effective in protecting phospho- 
rylase kinase from affinity labeling by 5’-FSBA we 
determined its effect on the inactivation caused by 
this analog. Table 2 shows the results of such an 
experiment in which inactivation of the enzyme by 
5’-FSBA was done in the absence or presence of ADP 
or MgADP. Despite the protection by ADP against 
labeling of the /I subunit, it offered relatively little 
protection against inactivation by 5’-FSBA. Never- 
theless, protection by ADP against inactivation again 
reached aplateau at <50 PM. The fact that bothlabeling 
of the p subunit and inactivation of phosphorylase 
kinase by 5’-FSBA were reduced in the presence of 
free ADP, but that this protective ffect reached a
plateau, could be explained by a model in which 
5’-FSBA and ADP bind to functionally distinct sites 
on the enzyme. In such a model saturation by ADP 
at one site would cause a decreased rate of affinity 
labeling by 5’-FSBA at a distinct site. Alternatively, 
Table 2 
Effect of ADP on inactivation by 5’-FSBA 
Additions 
5’-FSBA 
5’-FSBA + ADP (0.2 mM) 
5’-FSBA + Mg”+ (10 mM) 
5’-FSBA + Mg’+ (10 mM) + 
% Control activity 
50.4 + 1.4 
66.5 * 1.1 
24.9 f 4.4 
ADP (0.2 mM) 60.4 f 4.1 
Inactivation of phosphorylase kinase by 0.5 mM 5’-FSBA and 
assays for enzymatic activity were done as in fig.1 except 
that Mg(CH,CO,), and/or ADP were added to the inactivation 
mixture where indicated. The activity of phosphorylase kinase 
incubated in the absence of 5’-FSBA, but in the presence of 
the respective ffecters, represented 100% of control activity. 
The values shown are averages with standard deviations of 
results obtained in triplicate 
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similar esults would be obtained if there were 2 sep 
arate binding sites for 5’-FSBA on the p subunit, and 
if ADP competed predominantly at only one of the 
sites. 
Addition of Mg’+ only slightly influenced the pro- 
tection afforded by ADP against inactivation by 
5’.FSBA (table 2). Protection from inactivation by 
various concentrations of MgADP, when tested under 
the conditions and concentrations described for fig2B, 
did not show the plateau that it had with free ADP 
(not shown). Even though there was a large excess of 
free Mg2+ in these experiments, a known effector of 
phosphorylase kinase, the differences in the protec- 
tion from inactivation by ADP plus and minus Mg2+ 
was due to the effect of MgADP rather than free Mg2+. 
This is clearly seen in table 2, where it is shown that 
free Mg2’ enhances, rather than protects against, he 
inactivation by 5’-FSBA. 
5’-FSBAis an affinity label of phosphorylase kinase 
which preferentially labels the j3 subunit. Protection 
from labeling by this analog was obtained in the 
presence of PM levels of ADP, which suggests hat a 
high affinity binding site for free nucleotide xists on 
the enzyme. It is not yet possible to deduce the func- 
tion or location of this binding site; affinity labeling 
with an ADP analog of greater affinity and specificity 
than that obtained with 5’-FSBA may serve to answer 
these questions. 
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